SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-019443
Filing Date
2015-11-03
Accepted
2015-11-03 09:43:24
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20150930_10q.htm 10-Q 1162856
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14533
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14699
4 EXHIBIT 32 ex32.htm EX-32 6648
  Complete submission text file 0001437749-15-019443.txt   4060824

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS oxfd-20150930.xml EX-101.INS 603096
6 EXHIBIT 101.SCH oxfd-20150930.xsd EX-101.SCH 42236
7 EXHIBIT 101.CAL oxfd-20150930_cal.xml EX-101.CAL 51377
8 EXHIBIT 101.DEF oxfd-20150930_def.xml EX-101.DEF 285351
9 EXHIBIT 101.LAB oxfd-20150930_lab.xml EX-101.LAB 247816
10 EXHIBIT 101.PRE oxfd-20150930_pre.xml EX-101.PRE 305010
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 151192408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances